Drug Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

CMOs expand capacity and capabilities in high-potency manufacturing to meet strong demand for cytotoxic and other potent drugs.

CMOs Invest in High-Potency Manufacturing

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Legislative decisions to increase Medicare's formulary may lead to a fight over drug approvals.

FDA and Medicare at Odds?

The high-profile case of contaminated heparin from a Chinese supplier has intensified the debate on the effectiveness of FDA's process for inspecting foreign drug-manufacturing facilities. The article examines proposed legislative and regulatory reforms and actions taken by the agency to improve drug-import safety.

The Anatomy of the Changing Supply Chain

Also, Cobra Biomanufacturing to extend collaboration and form joint venture with ViroMed, Epix Pharmaceuticals CEO resigns, more...

Company and People Notes: Sanofi Pasteur to Acquire Acambis, West Appoints Matthew T. Mullarkey As COO, More...

As part of a new strategic direction, GlaxoSmithKline CEO Andrew Witty outlined three priorities that are designed to improve the company's long-term financial performance.

GSK CEO Witty Outlines Company's New Strategic Priorities

Senator Sherrod Brown sent a letter to Richard T. Clark, president and chief executive officer of Merck (Whitehouse Station, NJ), to ask for information about the company's reliance on global outsourcing for the manufacture of pharmaceutical ingredients and finished products.

Senator Brown Requests Information about Merck's Outsourcing Procedures

Roche plans to acquire the biopharmaceutical company Genentech (South San Francisco, CA) for $43.7 billion. Roche currently holds a 55.9% stake in Genentech and it plans to acquire the remaining publicly held minority interest that it does not own for $89 per share.

Roche to Acquire Genentech for $43.7 Billion

Also, Niro changes its name to GEA Process Engineering; Frances K. Heller joins Exelixis as executive vice-president of business development, more...

Company and People Notes: AMRI Opens In Vitro Laboratory in Singapore; Bristol-Myers Squibb Names Quentin Roach Senior Vice-President and Chief Procurement Officer, More ...

Also, Roche to end HIV/AIDS research program, WuXi PharmaTech makes appointments, more...

Company and People Notes: Solvay Pharma Raises Bid for Innogenetics, Catalent Appoints VP of Printed Components, More...

Also, Catalent Pharma Solutions to collaborate with One World Design and Manufacturing Group, Bioheart appoints Howard J. Leonhardt as CEO, more...

Ingredients